Vasodilating mechanisms of levosimendan: involvement of K+ channels
Clicks: 165
ID: 269234
2007
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
164 views
10 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Levosimendan, a novel agent developed for the treatment of acute and decompensated heart failure, exerts potent positive inotropic action and peripheral vasodilatory effects. The mechanism of vasodilation by levosimendan may involve reduction of Ca2+ sensitivity of contractile proteins in vascular s …
| Reference Key |
o2007journalvasodilating
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yildiz O;; |
| Journal | Journal of pharmacological sciences |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
simendan
hydrazones / pharmacology*
pyridazines / pharmacology*
pmid:17452812
doi:10.1254/jphs.cp0060010
oguzhan yildiz
blood vessels / drug effects
blood vessels / physiology
potassium channels / physiology*
vasodilation / drug effects*
vasodilation / physiology
vasodilator agents / pharmacology
ca2+ desensitization
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.